Quarterly Investor Report:

August 2023

Quarter ended 30 June 2023

Target Healthcare REIT plc and its subsidiaries ('the Group') is a leading investor in modern purpose-built UK care homes with en suite wet rooms. The Group's objective is to provide investors with an attractive quarterly dividend, generated from a portfolio diversified by tenant, geography and end-user payment profile, through responsible investment.

Group at a glance

Properties

97

Beds

6,705*

Tenants

32

Contracted rent

£56.6m

Property Value

£868.7m

Overview

Key ratios & financials

Launch date

March 2013**

Investment properties

£868.7 million

ISIN

GB00BJGTLF51

Drawn debt

£230.0 million

SEDOL

BJGTLF5

EPRA NTA

£647.9 million

Company name

Target Healthcare REIT plc

EPRA NTA per share

104.5 pence

Registered number

11990238

Quarterly NAV total return

2.4%

(including dividend)

Expected quarterly dividend

Feb/May/Aug/Nov

Quarterly Group specific

1.46 pence

adjusted EPRA earnings per

Financial year end

30 June

share

Currency

Sterling

Quarterly dividend per share

1.40 pence

Ordinary hare class as at

Website

www.targethealthcarereit.co.uk

Dividend yield (01/08/2023)

7.6%

01/08/2023

Loan-to-Value ('LTV')***

26.5% (gross); 24.7% (net)

Shares in issue

620,237,346

Management fee rate

1 05% up to £500m NAV

0.95% of £500m - £750m NAV

Share price

73.4 pence

0.85% of £750m - £1,000m NAV

Market capitalisation

£455.3 million

0.75% of £1,000m - £1,500m NAV

0.65% of £1,500m + NAV

Share price discount to EPRA

29.8%

WAULT

26.5 years

NTA

* Including planned beds in development sites

** Originally launched as Target Healthcare REIT Limited (Jersey registered: 112287)

*** Gross LTV calculated as total gross debt as a proportion of gross property value. Net LTV calculated as total gross debt less cash, as a proportion of gross property value

Recent news

Asset Management and I vestment Activity

reported by our tenants, and is demonstrated by growing

This quarter the conversion to 51 full ensuite wet-rooms from

Demand for places in our care homes remains encouraging, as

weekly fee rates and improving rent covers/profitability.

poorer quality ensuites at two care homes was completed,

Resident occupancy across the portfolio continues to recover

progressing plans to move the portfolio to 100% wet-rooms

towards pre-pandemic levels.

(currently 98% following these works). The Group signed

The Group's focus remains on managing the portfolio,

legal agreements relating to the addition of 18 bedrooms at a

supporting its tenants in their business aspirations and

property with works expected to complete by September

continuing to invest to improve the real estate when we see

2023.

the opportunity to unlock further value.

Post quarter-end, the Group acquired a site subject to a

The return to near-full rent collection for the quarter and the

forward funding agreement to construct a 66-bed care home

in Weston-super-Mare, which is pre-let to a new tenant to the

stability of the Group's portfolio valuation is consistent with

Group. The care home is to be built to exceptional ESG

its investment thesis - that modern, purpose-built care homes

standards, with the highest certifications anticipated, and will

will provide compelling long-term returns.

offer carbon net zero operational ability.

The portfolio value increased by 1.5% over the quarter,

comprising a like-for-like uplift in the operational portfolio

In addition to the above acquisition, we have four further sites

Performance

Outlook

(+0.9%), primarily reflecting inflation-linked rent reviews,

where pre-let care homes are being built which will deliver a

and further investment into the portfolio, mainly associated

pipeline of much-neededfit-for-purpose modern real estate

with the four development properties (+0.6%).

to the sector. The portfolio has 94% A or B EPC (100% A to C

ratings), currently compliant with the minimum energy

Contractual rent increased by 1.1%, largely as a

result of

efficiency standards anticipated to apply from 2030.

inflation-linked rent reviews in the quarter (+1.0%).

Summary balance sheet

£m

June-23

March-23

868.7

Property portfolio*

855.7

Cash

15.4

26.4

Net current assets/(liabilities)

(6.2)

(10.5)

Bank loans

(230.0)

(230.0)

Net assets

647.9

641.6

EPRA NTA per share (pence)

104.5

103.4

* Ignores the effect of fixed/guaranteed rent reviews. See note 9 to the Annual Report 2022 for full de

tails.

Performance - NAV and share price total return

205

195

NAV total return

185

175

Share price total return

165

155

145

135

125

115

105

95

Jun-13

Sep-13

Dec-13Mar-14Jun-14Sep-14Dec-14

Jun-15

Sep-15

Jun-16

Sep-16

Jun-17

Sep-17

Jun-18

Sep-18

Jun-19

Sep-19

Jun-20

Sep-20

Jun-21

Sep-21

Jun-22

Sep-22

Jun-23

Mar-13

Mar-15

Dec-15

Mar-16

Dec-16

Mar-17

Dec-17

Mar-18

Dec-18

Mar-19

Dec-19

Mar-20

Dec-20

Mar-21

Dec-21

Mar-22

Dec-22

Mar-23

Portfolio summary at 30 June 2023

Scotland

North East

Number of properties by geographic region

North West

Yorkshire & The Humber

Wales

East Midlands

West Midlands

East of England

South West

South East

Contracted rent by geographic region

2%1%

8

7%

5%

24%

7%

2

8%

17%

18

12%

17%

26

Valuation by geographic region (including

7

13

developments)

5

Wales

1

North East

13

East of England

4

South West

West Midlands

Scotland

East Midlands

North West

South East

Yorkshire & The Humber

0%

5%

10%

15%

20%

25%

AlisonDirectorsFyfe (Chair)

Michael Brodtman

Richard Cotton

Vince Niblett

Dr Amanda Thompsell

TargetInves meFundt Managers Ltd. Kenneth MacKenzie, Gordon Bland

+44 (0) 1786 845 912 targetfundmanagers.com

Administrator

Target Fund Managers Ltd.

visers

IQ EQ Depositary Company (UK) Ltd.

Depositary

Broker

Stifel Nicolaus Europe Ltd.

Legal

Dickson Minto W.S.

Auditors

Ernst & Young LLP

This Report is intended solely for the information of the person to whom it is provided by the Group, the Investment Manager or the Administrator. This Report is not intended as an offer or solicitation for the purchase of shares in the Group and should not be relied on by any person for the purpose of accounting, legal or tax advice or for making an investment decision. The payment of dividends and the repayment of capital are not guaranteed by the Group. Any forecast, projection or target is indicative only and is not guaranteed in any way, and any opinions expressed in this Report are not statements of fact and are subject to change, and neither the Group nor the Investment Manager is under any obligation to update such opinions. Past performance is not a reliable indicator of future performance, and investors may not get back the original amount invested. Unless otherwise stated, the sources for all information contained in this report are the Investment Manager and the Administrator. Information contained in this Report is believed to be accurate at the date of publication, but none of the Group, the Investment Manager and the Administrator gives any representation or warranty as to the Report's accuracy or completeness. This Report does not contain and is not to be taken as containing any financial product advice or financial product recommendation. None of the Group, the Investment Manager and the Administrator accepts any liability whatsoever for any loss (whether direct or indirect) arising from any use of this Report or its contents. Target Healthcare REIT plc, registered in the UK (Registered Number: 11990238). Registered Office: Level 4, Dashwood House, 69 Old Broad Street, London EC2M 1QS.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Target Healthcare REIT plc published this content on 07 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 August 2023 15:46:08 UTC.